✦ LIBER ✦

Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease

✍ Scribed by Venkatesh Atul Bhattaram; Ohidul Siddiqui; Leonard P. Kapcala; Jogarao V. S. Gobburu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How can we improve the design and endpoi

✍ C.E. Clarke 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 331 KB

Effects of Coenzyme Q10 in Huntington's

✍ M. Flint Beal; Clifford W. Shults 📂 Article 📅 2003 🏛 IOS Press 🌐 English ⚖ 62 KB

Challenges to the development of disease

✍ A. H. V. Schapira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Drug selection and timing of initiation

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Short- and long-term dopaminergic effect

✍ Sabine Skodda; Wenke Visser; Uwe Schlegel 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 188 KB

Sebum secretion in idiopathic Parkinson'

✍ J. C. B. Villares; E. A. Carlini 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB